Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma

Anticancer Research

Volumn 18, Issue 1 B, 1998, Pages 677-681

  Morell Quadreny, L ^a   Clar Blanch, F ^b   Fenollosa Enterna, B ^c   Perez Bacete, M ^a   Martinez Lorente, A ^a   Llombart Bosch, A ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Immunohistochemistry; Prognosis; Proliferation; Renal cell carcinoma

Indexed keywords

CYCLINE;

ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MITOSIS INDEX; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR NECROSIS;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NEPHRECTOMY; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES;

EID: 0031943381     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. McNichols W, Segura W and DeWeerd JH: Renal cell carcinoma: long term survival and late recurrence. J Urol 126: 17-23, 1981.
2. Medeiros J, Geb B and Weiss M: Renal cell carcinoma. Prognostic significance of morphological parameters in 121 cases. Cancer 61: 1639-1651, 1988.
3. Strokel S, Thoenes W, Jacobi H and Lipold R: Prognostic parameters in renal cell carcinoma. - A new approach. Eur Urol 16: 416-422, 1989.
4. Toschi L and Bravo R: Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J. Cell Biol. 107: 1623-1628, 1988.
5. Cronin K, Williams NN, Kerin MJ, Creagh TA and Dervan P: Proliferating cell nuclear antigen (PCNA) correlates with tumor grade in renal cell carcinoma. J Urol 147: 227a., 1992.
6. Oda H and Machinami R: Sarcomatoid renal cell carcinoma. A study of its proliferative activity. Cancer 71: 2292-2298, 1993.
7. Larsson P: Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis. Scand J Urol Nephrol suppl 165, 1994.
8. Flint A, Grossman HB, Liebert M, Lloyd RV and Bromberg J: DNA and PCNA content of renal cell carcinoma and prognosis. Am J Clin Pathol 103: 14-19, 1995.
9. Robson CJ, Churchil BM and Anderson W: The results of radical nephrectomy for renal cell carcinoma. J Urol 101: 297-301, 1969.
10. Fuhrman SA, Lasky LC and Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655-663, 1982.
11. Thoenes W, Storkel St and Rumpelt HJ: Histopathology and classification of renal cell tumors (Adenomas, Oncocytomas and Carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Path. Res. Pract. 181: 125-143, 1986.
12. Kaplan FL and Meier P: Non-parametric estimation from incomplete observations. Am Statistical Assoc J 53: 457-481, 1958
13. Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA, Barnes DM, Gillet CE, Camplejon R, Dover R, Waseem NH and Lane DP: Proliferating cell nuclear antigen (PCNA) inmunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285-294, 1990.
14. Figge Ch, Reifenberger G, Vogeley KT, Messing M, Roosen N and Wechsler W: Immunohistochemical demonstration of proliferating cell nuclear antigen in glioblastomas: Pronounced heterogeneity and lack of prognostic significance. J Cancer Res Clin Oncol 118: 289-295, 1992.
15. Rabes HM, Carl P, Meister P and Rattenhuber U: Analysis of proliferative compartments in human tumors. I Renal adenocarcinoma. Cancer 44: 799-813, 1979.
16. Skinner DG, Colvin RB, Vermillion CD, Pfister RC and Leadbetter WF: Diagnosis and management of renal cell carcinoma: A clinical and pathologic study of 309 cases. Cancer 28: 1165-1177, 1971.
17. Boczko S, Fromowitz F and Bard R: Papillary adenocarcinoma of kidney: A new perspective. Urology 14: 491-495, 1979.
18. Murphy GP and Mostofi FK: The significance of cytoplasmatic granularity in the prognosis of renal cell carcinoma. J Urol 4: 48-54, 1965.
19. Delahunt B, Bethwaite PB, Nacey JN and Ribas JL: Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumor grade, mitotic index, and silver-staining nucleolar organizer region numbers. J Pathol 170: 471-477, 1993.
20. Shameem IA, Shimabukuro T, Wada T, Kurisu H and Naito K: Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival. Eur Urol 29 (1): 78-84, 1996.
21. Harper M, Glynne-Jones L, Goddard L, Wilson W, Matenhelia S, Conn I, Peeling B and Griffiths K: Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinoma to various clinical parameters. Prostate 20: 243-249, 1992.
22. Skopelitou A, Korkolopoulou P, Papanicolaou A, Christodoulou P, Thomas-Tsagli E and Pavlakis K: Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Eur Urol 22: 235-240, 1992.
23. Tribukait B: Flow cytometry in assessing clinical aggressiveness of genito-urinary neoplasms. World J Urol 5: 108-122, 1987.
24. Siminovitch JMP, Montie JF and Straffon RA: Prognosis indicators in renal cell adenocarcinoma. J Urol 130: 20-23, 1983.
25. Mostofi FK, Sesterhen IH and Sobin LH: Histological typing of kidney tumors. In "International Histological Classification of Tumors" (25) World Health Organization, Geneva, 1981.
26. Amtrup F, Hansen JB and Thybo E: Prognosis in renal carcinoma evaluated from histological criteria. Scan J Urol Nephrol 8: 198-202, 1974.
27. Bottinger LE: Prognosis in renal cell carcinoma. Cancer 26: 780-787, 1970.
28. Tomera KM, Farrow GM and Lieber MM: Well differentiated (grade 1) clear cell carcinoma. J Urol 129: 933-937, 1983.
29. Hindermann W, Berndt A, Wunderlich H, Katenkamp D and Kosmehl H: Quantitative evaluation of apoptosis and proliferation in renal cell carcinoma. Correlation to tumor subtype, cytological grade according to Thoenes-classification and the occurrence of metastasis. Pathol Res Prac 193: 1-7, 1997.
30. Tannapfel A, Hahn HA, Katalinic A, Fietkan RJ, Kuhn R and Wittekind ChW: Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Cancer 77: 164-171, 1996.
31. Jochum W, Schroder S, Al-taha R, August C, Gross AJ, Berger J and Padberg BC: Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas. A clinicopathologic study of 58 patients using mitotic count, MIB-1 staining and DNA cytophotometry. Cancer 77: 514-521, 1996.